N
EXAS

Natixis’s Exact Sciences EXAS Stock Holding History

Natixis’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-212,463
Closed -$11.6M – 1182
2025
Q3 		$11.6M Buy
+212,463
New +$10.6M 0.05% 266
2024
Q1 		– Sell
-4,606
Closed -$341K – 1075
2023
Q4 		$341K Buy
+4,606
New +$302K ﹤0.01% 656
2022
Q4 		– Sell
-333,988
Closed -$10.9M – 1174
2022
Q3 		$10.9M Buy
333,988
+8,422
+3% +$347K 0.05% 266
2022
Q2 		$12.8M Buy
325,566
+286,241
+728% +$15.3M 0.05% 249
2022
Q1 		$2.75M Sell
39,325
-26,177
-40% -$1.91M 0.01% 676
2021
Q4 		$5.1M Sell
65,502
-219,187
-77% -$19.3M 0.02% 550
2021
Q3 		$27.2M Buy
284,689
+109,877
+63% +$11.6M 0.09% 192
2021
Q2 		$21.7M Sell
174,812
-696,330
-80% -$83.1M 0.09% 182
2021
Q1 		$115M Sell
871,142
-188,825
-18% -$25.8M 0.38% 48
2020
Q4 		$140M Sell
1,059,967
-59,766
-5% -$7.23M 0.51% 36
2020
Q3 		$114M Buy
+1,119,733
New +$96.7M 0.84% 26

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Natixis's EXAS Position: Q4 2025 in Review

Natixis sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 212,463 shares — an estimated $11.6M sold.

Natixis first reported a position in EXAS in Q3 2020 and held it in 11 quarters. The position peaked at $140M in Q4 2020. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Natixis reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Natixis sold 212,463 Exact Sciences shares in Q4 2025, an estimated $11.6M.
  • Natixis first reported a position in Exact Sciences in Q3 2020 and held it in 11 quarters.
  • Natixis's Exact Sciences position peaked at $140M in Q4 2020.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Natixis's 13F filing for Q4 2025, filed 13 Feb 2026.